6-Hydroxydopamine as a tool to understand adaptive immune system-induced dopamine neurodegeneration in Parkinson's disease

Immunopharmacol Immunotoxicol. 2015;37(4):393-9. doi: 10.3109/08923973.2015.1070172. Epub 2015 Jul 27.

Abstract

Context: Neuroimmunological response is associated with neurodegeneration in the human substantia nigra (SN) in Parkinson's disease (PD).

Objective: To explore the possibility that the neurotoxin, 6-hydroxydopamine (6-OHDA), could be used as a tool in mice to understand the immune response in PD.

Materials and methods: We employed unilateral administration of 6-OHDA into the mouse SN. At 1 week, 2 weeks and 4 weeks post-injection, we used immunohistochemistry for the markers Iba-1 and gp91PHOX to investigate activated microglia in the SN. To examine the adaptive immune response, we used immunohistochemistry for CD3-positive T-lymphocytes, CD45R-positive B-lymphocytes and anti-mouse immunoglobulin-G (IgG). Dopamine neuron loss was examined using immunohistochemistry for the dopamine neuron marker, tyrosine hydroxylase.

Results: Compared to vehicle, 6-OHDA administration induced an intense IgG deposition in the SN as well as increased infiltration of both T- and B- lymphocytes into the injected side of the midbrain. The adaptive immune response was associated with extensive destruction of dopamine neurons and extensive microglial activation at every time point in the 6-OHDA groups.

Conclusion: Our results suggest that 6-OHDA administration in mice can a potential tool for understanding mechanisms underlying adaptive immune activation-induced neurodegeneration in PD.

Keywords: Glia; immunoglobulins; lymphocytes; neuroimmunology; neurotoxin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptive Immunity / drug effects*
  • Animals
  • B-Lymphocytes / drug effects
  • B-Lymphocytes / immunology
  • CD3 Complex / immunology
  • Calcium-Binding Proteins / metabolism
  • Disease Models, Animal
  • Dopaminergic Neurons / drug effects
  • Dopaminergic Neurons / immunology
  • Dopaminergic Neurons / pathology
  • Immunoglobulin G / immunology
  • Immunohistochemistry
  • Leukocyte Common Antigens / immunology
  • Male
  • Membrane Glycoproteins / metabolism
  • Mice, Inbred C57BL
  • Microfilament Proteins / metabolism
  • Microglia / drug effects
  • Microglia / immunology
  • Microglia / metabolism
  • NADPH Oxidase 2
  • NADPH Oxidases / metabolism
  • Nerve Degeneration / drug therapy*
  • Nerve Degeneration / immunology
  • Nerve Degeneration / pathology
  • Oxidopamine / pharmacology*
  • Parkinsonian Disorders / immunology*
  • Parkinsonian Disorders / pathology
  • Substantia Nigra / drug effects*
  • Substantia Nigra / immunology
  • Substantia Nigra / pathology
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology

Substances

  • Aif1 protein, mouse
  • CD3 Complex
  • Calcium-Binding Proteins
  • Immunoglobulin G
  • Membrane Glycoproteins
  • Microfilament Proteins
  • Oxidopamine
  • Cybb protein, mouse
  • NADPH Oxidase 2
  • NADPH Oxidases
  • Leukocyte Common Antigens